Defining Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer

This multicenter cohort study assess the accuracy of each definition of hyperprogressive disease to identify the frequency and associations with poorer outcomes of immune-checkpoint inhibitor therapy in patients with advanced non–small cell lung cancer and offers an optimized and homogenized…

Read the full article here

Related Articles